Source Date | Board Meeting Date | Details |
01-Apr-2025
|
09-Apr-2025
|
Inter alia, to consider and approve:- (1) To allot 1,20,06,831 (One Crore Twenty Lakhs Six Thousand Eight Hundred and Thirty One) fully convertible warrants to promoters/promoter group on private placement basis through preferential issue approved by the shareholders of the company in Extraordinary General Meeting (?EGM?) held on March 12, 2025 and as per the in-principle Approval letters dated March 28, 2025 received from BSE Limited and National Stock Exchange of India Ltd. for the same.
|
03-Feb-2025
|
11-Feb-2025
|
Quarterly Results & Preferential Issue of shares
|
03-Jan-2025
|
09-Jan-2025
|
Inter alia to consider the following matters:- 1. To consider and evaluate the raising of funds through issue of equity shares and/or any other eligible securities, including but not limited to warrants, depository receipts, FCCBs or any combination thereof or securities representing equity shares or convertible into or exchangeable for equity shares, through preferential issue, qualified institutions placement, further public offer, rights issue, debt issue, ADR, GDR, FCCB or such other permissible mode or combination thereof, as may be considered appropriate, subject to the approval of the members of the Company and other regulatory and/or statutory approvals, as applicable; 2. Any other business with the permission of the chair.
|
06-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
30-Jul-2024
|
13-Aug-2024
|
Quarterly Results
|
17-May-2024
|
27-May-2024
|
Right Issue of Equity Shares & Audited Results & Final Dividend
|
29-Feb-2024
|
05-Mar-2024
|
Increase in Authorised Capital
|
31-Jan-2024
|
09-Feb-2024
|
Quarterly Results
|
26-Oct-2023
|
07-Nov-2023
|
Quarterly Results
|
25-Jul-2023
|
04-Aug-2023
|
Final Dividend & Quarterly Results
|
09-May-2023
|
19-May-2023
|
Audited Results
|
31-Jan-2023
|
13-Feb-2023
|
Quarterly Results
|
04-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|
18-Jul-2022
|
26-Jul-2022
|
Final Dividend & Quarterly Results Inter alia, to consider and approve :- 1. Final dividend on the equity shares of the Company for the Financial Year 2021-2022, subject to the declaration of the same by the Shareholders in the ensuing Annual General Meeting. 2. issuance of Non-Convertible Debentures on private placement basis, in one or more tranches from time to time, subject to the approval of Shareholders in the ensuing Annual General Meeting.
|
25-Apr-2022
|
04-May-2022
|
Increase in Authorised Capital & Bonus issue & Audited Results Inter alia, to consider and approve : 1. Audited Financial Results of the Company for the Quarter and Year ended on March 31, 2022 along with the statement of assets and liabilities as on that date and cash flow statement for the year ended on March 31, 2022 and to take on record Auditor?s report thereon. 2. Recommendation for increase in Authorised Share Capital of the Company and consequent alteration of Capital clause of Memorandum of Association of the Company. 3. Recommendation for issue of bonus equity shares of the Company. 4. Recommendation for change of name of the Company and consequent alteration in Memorandum of Association (?MOA?) and Articles of Association (?AOA?) of the Company. 5. Notice of Postal Ballot.
|
02-Feb-2022
|
18-Feb-2022
|
Stock Split
|
17-Jan-2022
|
25-Jan-2022
|
Quarterly Results
|
01-Nov-2021
|
12-Nov-2021
|
Quarterly Results
|
05-Aug-2021
|
13-Aug-2021
|
Quarterly Results
|
10-Jun-2021
|
22-Jun-2021
|
Final Dividend & Audited Results
|